DeepMed Research

Georgetown University

🇬🇹Guatemala

Country: 🇬🇹Guatemala

Ownership: Private

Established: 1789-01-23

Employees: 5K

Market Cap: -

Website: http://www.georgetown.edu

Clinical Trials

Testing a Culturally Adapted Telephone Genetic Counseling Intervention

Not Applicable

Completed

Conditions: Hereditary Breast Cancer
Breast Cancer

Interventions: Behavioral: Telephone Genetic Counseling

First Posted Date: 2019-05-22

Last Posted Date: 2021-09-01

Lead Sponsor: Georgetown University

Target Recruit Count: 37

Registration Number: NCT03959267

Locations: 🇺🇸
Nueva Vida, Alexandria, Virginia, United States
🇺🇸
Capital Breast Care Center, Washington, District of Columbia, United States
🇺🇸
Hackensack Meridian Health, Hackensack, New Jersey, United States

and more 1 locations

Metta Meditation Training on Prosocial Behavior

Not Applicable

Completed

Conditions: Social Behavior

Interventions: Behavioral: Metta meditation

First Posted Date: 2019-03-29

Last Posted Date: 2021-06-16

Lead Sponsor: Georgetown University

Target Recruit Count: 67

Registration Number: NCT03894930

Locations: 🇺🇸
Georgetown University, Washington, District of Columbia, United States

Impact of Bosutinib on Safety, Tolerability, Biomarkers and Clinical Outcomes in Dementia With Lewy Bodies

Phase 2

Completed

Conditions: Dementia With Lewy Bodies

Interventions: Drug: Bosutinib Oral Tablet
Drug: Placebo Oral Tablet

First Posted Date: 2019-03-25

Last Posted Date: 2022-04-05

Lead Sponsor: Georgetown University

Target Recruit Count: 26

Registration Number: NCT03888222

Locations: 🇺🇸
MedStar Georgetown University Hospital, Washington, District of Columbia, United States

Study of Proton Therapy in Adjuvant Pancreatic Cancer

Phase 1

Completed

Conditions: Resected Pancreatic Adenocarcinoma

Interventions: Drug: mFOLFIRINOX
Radiation: Proton beam radiation

First Posted Date: 2019-03-21

Last Posted Date: 2024-10-24

Lead Sponsor: Georgetown University

Target Recruit Count: 9

Registration Number: NCT03885284

Locations: 🇺🇸
Georgetown University Medical Center - Lombardi Comprehensive Cancer Center, Washington, District of Columbia, United States

WI231696: Bosutinib, Palbocicilib and Fulvestrant for HR+HER2- Advanced Breast Cancer Refractory to a CDK4/6 Inhibitor

Phase 1

Completed

Conditions: Metastatic Breast Cancer
Hormone Receptor Positive Breast Cancer
Human Epidermal Growth Factor 2 Negative Carcinoma of Breast

Interventions: Drug: Palbociclib
Drug: Bosutinib
Drug: Fulvestrant

First Posted Date: 2019-02-26

Last Posted Date: 2025-02-06

Lead Sponsor: Georgetown University

Target Recruit Count: 19

Registration Number: NCT03854903

Locations: 🇺🇸
Lombardi Comprehensive Cancer Center, Washington, District of Columbia, United States

Nilotinib in Huntington's Disease

Phase 1

Conditions: Huntington Disease

Interventions: Drug: Nilotinib 150 MG

First Posted Date: 2018-12-05

Last Posted Date: 2020-02-20

Lead Sponsor: Georgetown University

Target Recruit Count: 10

Registration Number: NCT03764215

Locations: 🇺🇸
Georgetown University Medical Center, Washington, District of Columbia, United States

Mechanisms of Preventing Antibiotic-Associated Diarrhea and the Role for Probiotics

Early Phase 1

Completed

Conditions: Antibiotic-associated Diarrhea

Interventions: Drug: Amoxicillin-Clavulanate 875 Mg-125 Mg Oral Tablet
Biological: BB-12
Other: Control

First Posted Date: 2018-11-28

Last Posted Date: 2023-02-17

Lead Sponsor: Georgetown University

Target Recruit Count: 66

Registration Number: NCT03755765

Locations: 🇺🇸
Georgetown University Department of Family Medicine, Washington, District of Columbia, United States

DC Longitudinal Study on Aging and Specimen Bank

Recruiting

Conditions: Alzheimer Disease
Aging Disorder
Dementia
Mild Cognitive Impairment
Aging

First Posted Date: 2018-10-11

Last Posted Date: 2019-10-24

Lead Sponsor: Georgetown University

Target Recruit Count: 1000

Registration Number: NCT03702907

Locations: 🇺🇸
Georgetown University Memory Disorders Program, Washington, District of Columbia, United States

Investigation of a Novel Wound Gel to Improve Wound Healing in Chronic Wounds

Phase 4

Completed

Conditions: Wound Infection

Interventions: Other: standard of care topical gel
Drug: Benzalkonium Gel
Procedure: Debridement
Drug: benzalkonium irrigation
Other: Saline Irrigation (SOC Irrigation)

First Posted Date: 2018-09-27

Last Posted Date: 2022-06-02

Lead Sponsor: Georgetown University

Target Recruit Count: 11

Registration Number: NCT03686904

Locations: 🇺🇸
Medstar Georgetown University Hospital, Washington, District of Columbia, United States

Optimizing Risk Messages for Waterpipe Tobacco Cessation in Young Adults

Not Applicable

Completed

Conditions: Hookah Smoking

Interventions: Behavioral: Hookah tobacco risk messages

First Posted Date: 2018-07-23

Last Posted Date: 2021-10-20

Lead Sponsor: Georgetown University

Target Recruit Count: 349

Registration Number: NCT03595280

Locations: 🇺🇸
Georgetown University, Washington, District of Columbia, United States
🇺🇸
Duke University, Durham, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy